News
CPHI, Milan 2024
Join DALI’s CEO and co-founder, Mr. David Daily and VP Business Development & Marketing, Mr. Ziv Cahani at CPHI, Milan 2024 .
We’d love to connect! Contact us to schedule a meeting and discover our latest innovations.
Pharmapack 2024
Discover DALI’s comprehensive range of injection products at Pharmapack 2024 .
Make sure to visit Booth H18 for an exclusive look.
DALI Medical Devices Delights in Another Remarkable Milestone Attained by Everads Therapy
DALI Medical Devices is pleased to share a noteworthy development involving our partner, Everdas Therapy. Everads Therapy is thrilled to reveal an exclusive license and collaboration agreement with Kriya to progress gene therapies for common ophthalmological conditions, such as Geographic Atrophy. This achievement is a significant milestone for our collaboration.
For more information click here
0 Read More
DALI Medical’s SAN®Light Passive Safety Needle coupled with a novel Drug Product, Enabling User-friendly Administration
DALI’s novel safety needle – SAN®Light – launched with ADVANZ PHARMA’s MYTOLAC®/MYRELEZ® drug product.
For more information click here
Read More
DALI Medical Devices is excited to announce a significant achievement by Everads Therapy
DALI Medical Devices is excited to announce a significant achievement by Everads Therapy (DALI’s spin-off). Through a collaborative effort involving Dr. Barak, Dr. Lawrence from the CRO, and Drs. Rotenstreich and Sher from Sheba, we have successfully secured the acceptance of a manuscript in the prestigious TVST journal of ARVO. This achievement marks a pivotal milestone in showcasing the functionality of our device in NHP.
For more information click here
0 Read More
Pharmapack 2023
DALI’s team will exhibit our latest innovative products at Pharmapack 2023 .
Come & Visit us at Booth E88.
CPHI, Frankfurt 2022
DALI’s CEO and co-founder, Mr. David Daily and VP Business Development & Marketing, Mr. Ziv Cahani will be attending CPHI, Frankfurt 2022 .
Contact us to schedule a meeting.
